A clinical study has confirmed elevated expression of NLRP3 inflammasome components in serum samples from pancreatitis patients compared to healthy controls, with NLRP3 activation correlating positively with disease severity (Algaba-Chueca et al., 2017). This evidence concerns the gene NLRP3 and pancreatitis.